ELOXX PHARMACEUTICALS, INC. Stock-Based Compensation
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Stock-Based Compensation of $141.00 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $95.00K, a 493.75% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $46.00K, a 130.00% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $16.00K.
- ELOXX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $20.00K.
- ELOXX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $3.02M, a 67.04% decline from fiscal 2021.
- ELOXX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $9.17M, a 5.78% increase from fiscal 2020.
- ELOXX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $8.67M, a 23.55% decline from fiscal 2019.
- ELOXX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $11.34M, a 15.21% decline from fiscal 2018.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 159 month | Share-based Payment Arrangement, Noncash Expense 162 month | Share-based Payment Arrangement, Noncash Expense 165 month | Share-based Payment Arrangement, Noncash Expense 168 month | Share-based Payment Arrangement, Noncash Expense 171 month | Share-based Payment Arrangement, Noncash Expense 174 month | Share-based Payment Arrangement, Noncash Expense 177 month | Share-based Payment Arrangement, Noncash Expense 180 month | Share-based Payment Arrangement, Noncash Expense 183 month | Share-based Payment Arrangement, Noncash Expense 186 month | Share-based Payment Arrangement, Noncash Expense 189 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $95.00K derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | $141.00K S-1 · filed 2026-09-11 | ||||||||||||||
| 2026-03-31 | $46.00K S-1/A · filed 2026-06-04 | |||||||||||||||
| 2025-12-31 | $235.00K S-1 · filed 2026-09-11 | |||||||||||||||
| 2025-06-30 | $16.00K derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | $36.00K S-1 · filed 2026-09-11 | ||||||||||||||
| 2025-03-31 | $20.00K S-1/A · filed 2026-06-04 | |||||||||||||||
| 2024-12-31 | $541.00K S-1 · filed 2026-09-11 | |||||||||||||||
| 2023-12-31 | $340.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-11 | $758.00K derived: sum of 2 quarters · filed 2026-09-11 | $1.37M derived: sum of 3 quarters · filed 2026-09-11 | $1.97M S-1 · filed 2026-09-11 | ||||||||||||
| 2023-09-30 | $418.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.03M derived: sum of 2 quarters · filed 2023-11-13 | $1.63M 10-Q · filed 2023-11-13 | $2.27M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2023-06-30 | $610.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.21M 10-Q · filed 2023-08-11 | $1.85M derived: sum of 3 quarters · filed 2023-08-11 | $2.56M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2023-03-31 | $597.00K 10-Q · filed 2023-05-12 | $1.24M derived: sum of 2 quarters · filed 2023-05-12 | $1.95M derived: sum of 3 quarters · filed 2023-11-13 | $2.70M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2022-12-31 | $641.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.35M derived: sum of 2 quarters · filed 2023-11-13 | $2.10M derived: sum of 3 quarters · filed 2023-11-13 | $3.02M 10-K · filed 2023-03-31 | ||||||||||||
| 2022-09-30 | $714.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.46M derived: sum of 2 quarters · filed 2023-11-13 | $2.38M 10-Q · filed 2023-11-13 | $3.98M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2022-06-30 | $744.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.67M 10-Q · filed 2023-08-11 | $3.27M derived: sum of 3 quarters · filed 2023-08-11 | $5.49M derived: sum of 4 quarters · filed 2023-08-11 | ||||||||||||
| 2022-03-31 | $922.00K 10-Q · filed 2023-05-12 | $2.52M derived: sum of 2 quarters · filed 2023-05-12 | $4.75M derived: sum of 3 quarters · filed 2023-05-12 | $8.78M derived: sum of 4 quarters · filed 2023-05-12 | ||||||||||||
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.82M derived: sum of 2 quarters · filed 2023-03-31 | $7.86M derived: sum of 3 quarters · filed 2023-03-31 | $9.17M 10-K · filed 2023-03-31 | ||||||||||||
| 2021-09-30 | $2.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $6.26M derived: sum of 2 quarters · filed 2022-11-10 | $7.57M 10-Q · filed 2022-11-10 | $8.85M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||
| 2021-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $5.34M 10-Q · filed 2022-08-12 | $6.62M derived: sum of 3 quarters · filed 2022-08-12 | $8.04M derived: sum of 4 quarters · filed 2022-08-12 | ||||||||||||
| 2021-03-31 | $1.31M 10-Q · filed 2022-05-06 | $2.59M derived: sum of 2 quarters · filed 2022-05-06 | $4.00M derived: sum of 3 quarters · filed 2022-05-06 | $5.98M derived: sum of 4 quarters · filed 2022-05-06 | ||||||||||||
| 2020-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $2.69M derived: sum of 2 quarters · filed 2022-03-30 | $4.67M derived: sum of 3 quarters · filed 2022-03-30 | $8.67M 10-K · filed 2022-03-30 | ||||||||||||
| 2020-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.39M derived: sum of 2 quarters · filed 2021-11-08 | $7.38M 10-Q · filed 2021-11-08 | $10.09M derived: sum of 4 quarters · filed 2022-03-30 | ||||||||||||
| 2020-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $5.97M 10-Q · filed 2021-08-16 | $8.68M derived: sum of 3 quarters · filed 2022-03-30 | $11.63M derived: sum of 4 quarters · filed 2022-03-30 | ||||||||||||
| 2020-03-31 | $4.00M 10-Q · filed 2021-05-07 | $6.70M derived: sum of 2 quarters · filed 2022-03-30 | $9.66M derived: sum of 3 quarters · filed 2022-03-30 | $12.67M derived: sum of 4 quarters · filed 2022-03-30 | ||||||||||||
| 2019-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $5.66M derived: sum of 2 quarters · filed 2022-03-30 | $8.68M derived: sum of 3 quarters · filed 2022-03-30 | $11.34M 10-K · filed 2022-03-30 | ||||||||||||
| 2019-09-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $5.97M derived: sum of 2 quarters · filed 2020-11-06 | $8.63M 10-Q · filed 2020-11-06 | $12.39M derived: sum of 4 quarters · filed 2021-03-12 | ||||||||||||
| 2019-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $5.67M 10-Q · filed 2020-08-07 | $9.44M derived: sum of 3 quarters · filed 2021-03-12 | $12.13M derived: sum of 4 quarters · filed 2021-03-12 | ||||||||||||
| 2019-03-31 | $2.66M 10-Q · filed 2020-05-08 | $6.42M derived: sum of 2 quarters · filed 2021-03-12 | $9.12M derived: sum of 3 quarters · filed 2021-03-12 | $15.29M derived: sum of 4 quarters · filed 2021-03-12 | ||||||||||||
| 2018-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $6.46M derived: sum of 2 quarters · filed 2021-03-12 | $12.63M derived: sum of 3 quarters · filed 2021-03-12 | $13.37M 10-K · filed 2021-03-12 | ||||||||||||
| 2018-09-30 | $2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $8.87M derived: sum of 2 quarters · filed 2019-11-06 | $9.61M 10-Q · filed 2019-11-06 | $9.67M derived: sum of 4 quarters · filed 2020-03-06 | ||||||||||||
| 2018-06-30 | $6.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $6.91M 10-Q · filed 2019-08-07 | $6.98M derived: sum of 3 quarters · filed 2020-03-06 | $6.98M derived: sum of 4 quarters · filed 2020-03-06 | ||||||||||||
| 2018-03-31 | $735.00K 10-Q · filed 2019-05-09 | $798.00K derived: sum of 2 quarters · filed 2020-03-06 | $798.63K derived: sum of 3 quarters · filed 2020-03-06 | $808.63K derived: sum of 4 quarters · filed 2020-03-06 | ||||||||||||
| 2017-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $63.63K derived: sum of 2 quarters · filed 2020-03-06 | $73.63K derived: sum of 3 quarters · filed 2020-03-06 | $101.00K 10-K · filed 2020-03-06 | ||||||||||||
| 2017-09-30 | $626.00 10-Q · filed 2017-11-14 | $10.63K derived: sum of 2 quarters · filed 2018-08-10 | $38.00K 10-Q · filed 2018-11-08 | $18.57K derived: sum of 4 quarters · filed 2018-08-10 | ||||||||||||
| 2017-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $21.00K 10-Q · filed 2018-08-10 | $17.94K derived: sum of 3 quarters · filed 2018-08-10 | $80.11K 10-K · filed 2017-10-13 | ||||||||||||
| 2017-03-31 | $11.00K 10-Q · filed 2018-05-10 | $74.33K 10-Q · filed 2017-05-22 | $7.94K derived: sum of 2 quarters · filed 2018-05-10 | $79.48K 10-Q · filed 2017-05-22 | $77.82K derived: sum of 4 quarters · filed 2018-05-10 | |||||||||||
| 2016-12-31 | -$3.06K 10-Q · filed 2017-02-10 | $5.15K 10-Q · filed 2017-02-10 | $66.82K derived: sum of 3 quarters · filed 2017-11-14 | $78.00K 10-K · filed 2019-03-14 | ||||||||||||
| 2016-09-30 | $8.21K 10-Q · filed 2017-11-14 | $69.88K derived: sum of 2 quarters · filed 2017-11-14 | $76.05K derived: sum of 3 quarters · filed 2017-11-14 | $140.41K derived: sum of 4 quarters · filed 2017-11-14 | ||||||||||||
| 2016-06-30 | $61.67K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $67.84K derived: sum of 2 quarters · filed 2017-10-13 | $132.20K derived: sum of 3 quarters · filed 2017-10-13 | $156.68K 10-K · filed 2017-10-13 | ||||||||||||
| 2016-03-31 | $6.17K 10-Q · filed 2017-05-22 | $70.53K derived: sum of 2 quarters · filed 2017-05-22 | $95.01K 10-Q · filed 2017-05-22 | -$302.88K derived: sum of 4 quarters · filed 2017-10-13 | ||||||||||||
| 2015-12-31 | $64.36K 10-Q · filed 2017-02-10 | $88.83K 10-Q · filed 2017-02-10 | -$309.06K derived: sum of 3 quarters · filed 2017-10-13 | $92.00K 10-K · filed 2018-03-16 | ||||||||||||
| 2015-09-30 | $23.48K 10-Q · filed 2016-11-14 | -$373.42K derived: sum of 2 quarters · filed 2017-10-13 | $124.98K derived: sum of 3 quarters · filed 2017-10-13 | $365.02K derived: sum of 4 quarters · filed 2017-10-13 | ||||||||||||
| 2015-06-30 | -$396.89K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $101.51K derived: sum of 2 quarters · filed 2017-10-13 | $341.55K derived: sum of 3 quarters · filed 2017-10-13 | $480.68K 10-K · filed 2017-10-13 | ||||||||||||
| 2015-03-31 | $498.40K 10-Q · filed 2016-05-12 | $738.44K derived: sum of 2 quarters · filed 2016-05-12 | $877.57K 10-Q · filed 2016-05-12 | $1.44M derived: sum of 4 quarters · filed 2016-10-13 | ||||||||||||
| 2014-12-31 | $240.04K 10-Q · filed 2016-02-16 | $379.17K 10-Q · filed 2016-02-16 | $940.42K derived: sum of 3 quarters · filed 2016-10-13 | $1.21M derived: sum of 4 quarters · filed 2016-10-13 | ||||||||||||
| 2014-09-30 | $139.13K 10-Q · filed 2015-11-16 | $700.38K derived: sum of 2 quarters · filed 2016-10-13 | $969.10K derived: sum of 3 quarters · filed 2016-10-13 | $1.31M derived: sum of 4 quarters · filed 2016-10-13 | ||||||||||||
| 2014-06-30 | $561.25K derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | $829.97K derived: sum of 2 quarters · filed 2016-10-13 | $1.17M derived: sum of 3 quarters · filed 2016-10-13 | $1.30M 10-K · filed 2016-10-13 | ||||||||||||
| 2014-03-31 | $268.72K 10-Q · filed 2015-05-14 | $611.51K derived: sum of 2 quarters · filed 2015-05-14 | $735.98K 10-Q · filed 2015-05-14 | $908.37K derived: sum of 4 quarters · filed 2015-10-09 | $13.57M 10-Q · filed 2014-05-09 | |||||||||||
| 2013-12-31 | $342.79K 10-Q · filed 2015-02-17 | $467.26K 10-Q · filed 2015-02-17 | $639.65K derived: sum of 3 quarters · filed 2015-10-09 | $841.82K derived: sum of 4 quarters · filed 2015-10-09 | $13.30M 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $124.47K 10-Q · filed 2014-11-14 | $296.86K derived: sum of 2 quarters · filed 2015-10-09 | $499.03K derived: sum of 3 quarters · filed 2015-10-09 | $695.60K derived: sum of 4 quarters · filed 2015-10-09 | $12.96M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $172.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | $374.56K derived: sum of 2 quarters · filed 2015-10-09 | $571.13K derived: sum of 3 quarters · filed 2015-10-09 | $724.69K 10-K · filed 2015-10-09 | $12.83M 10-K · filed 2013-09-11 | |||||||||||
| 2013-03-31 | $202.17K 10-Q · filed 2014-05-09 | $398.74K derived: sum of 2 quarters · filed 2014-05-09 | $552.30K 10-Q · filed 2014-05-09 | $708.43K derived: sum of 4 quarters · filed 2014-09-29 | $12.66M 10-Q · filed 2013-05-15 | |||||||||||
| 2012-12-31 | $196.57K 10-Q · filed 2014-02-14 | $350.13K 10-Q · filed 2014-02-14 | $506.26K derived: sum of 3 quarters · filed 2014-09-29 | $708.11K derived: sum of 4 quarters · filed 2014-09-29 | $12.46M 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | $153.56K 10-Q · filed 2013-11-14 | $309.69K derived: sum of 2 quarters · filed 2014-09-29 | $511.54K derived: sum of 3 quarters · filed 2014-09-29 | $796.01K derived: sum of 4 quarters · filed 2014-09-29 | $12.26M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $156.13K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $357.98K derived: sum of 2 quarters · filed 2014-09-29 | $642.45K derived: sum of 3 quarters · filed 2014-09-29 | $766.00K 10-K · filed 2014-09-29 | $12.11M 10-K/A · filed 2012-10-26 | |||||||||||
| 2012-03-31 | $201.85K 10-Q · filed 2013-05-15 | $486.32K derived: sum of 2 quarters · filed 2013-05-15 | $609.88K 10-Q · filed 2013-05-15 | $792.22K derived: sum of 4 quarters · filed 2013-09-11 | $11.95M 10-Q · filed 2012-05-14 | |||||||||||
| 2011-12-31 | $284.48K 10-Q · filed 2013-02-14 | $408.03K 10-Q · filed 2013-02-14 | $590.37K derived: sum of 3 quarters · filed 2013-09-11 | $753.66K derived: sum of 4 quarters · filed 2013-09-11 | $11.75M 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | $123.55K 10-Q · filed 2012-11-14 | $305.89K derived: sum of 2 quarters · filed 2013-09-11 | $469.18K derived: sum of 3 quarters · filed 2013-09-11 | $655.30K derived: sum of 4 quarters · filed 2013-09-11 | $11.46M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $182.34K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $345.63K derived: sum of 2 quarters · filed 2013-09-11 | $531.75K derived: sum of 3 quarters · filed 2013-09-11 | $750.37K 10-K · filed 2013-09-11 | ||||||||||||
| 2011-03-31 | $163.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | $349.41K derived: sum of 2 quarters · filed 2012-05-14 | $568.02K 10-Q · filed 2012-05-14 | |||||||||||||
| 2010-12-31 | $186.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | $404.73K 10-Q · filed 2012-02-14 | ||||||||||||||
| 2010-09-30 | $218.61K 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | $386.64K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |